Cargando…
High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma
BACKGROUND: Whether microRNA-130b(miR-130b) can serve as a prognostic biomarker of hepatocellular carcinoma (HCC) has not been investigated. In the present study, we investigated the feasibility of miR-130b as a novel prognostic biomarker for HCC. METHODS: We retrospectively investigated 97 patients...
Autores principales: | Wang, Wen-yao, Zhang, Hong-fei, Wang, Lei, Ma, Yan-peng, Gao, Fei, Zhang, Shao-jun, Wang, Li-chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141946/ https://www.ncbi.nlm.nih.gov/pubmed/25123453 http://dx.doi.org/10.1186/s13000-014-0160-5 |
Ejemplares similares
-
Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017) -
Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma
por: Li, Bin-Kui, et al.
Publicado: (2014) -
MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis
por: Huang, Xiao-Ying, et al.
Publicado: (2013) -
Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
por: Shao, Xuyang, et al.
Publicado: (2022) -
Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)